Directly targeting glycosyltransferases such as B3GNT3 in pancreatic cancer or ALG3 to induce immunogenic ferroptosis represents a promising strategy, particularly given the ability of ALG3 inhibition to enhance immunotherapy responses [41,42,59]. The gene discussed is ALG3; the disease is familial pancreatic carcinoma.